Donate

What Does it Mean to be in the NSMP Category of Uterine Cancer?

What Does it Mean to be in the NSMP Category of Uterine Cancer?

Stephanie Gaillard, MD PHD, Director, Gynecologic Cancer Trials and Co-Director, Developmental Therapeutics/Phase I Clinical Trials Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. Dr. Gaillard will explain what the No Specific Molecular Profile (NSMP) category of endometrial/uterine cancer is and tell us about the research that is going on in the various subcategories of NSMP. […]

ASCO 2025: What’s New for MBC?

ASCO 2025 What’s New for MBC

Get the latest updates from the 2025 ASCO Annual Meeting on metastatic breast cancer. Our expert, Dr. Ashley Schreier, breast oncologist at Weill Cornell Medicine, will break down key research and what it means for people living with MBC. Stay informed, ask questions, and join the conversation.

BRIA-ABC

MBC

Listen to Dr. Kelly McCann to learn about the BRIA-ABC clinical trial, a Phase 3 study evaluating a novel immunotherapy approach for patients with advanced metastatic or locally recurrent breast cancer. This multicenter, randomized, open-label trial compares three groups: one receiving Bria-IMT—a whole-cell cancer vaccine—combined with retifanlimab, an immune checkpoint inhibitor; a second group receiving […]

Report Back from SGO: What’s New in Cervical Cancer?

Report Back from SGO Cervical Cancer 2025

Join us for a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Claire Hoppenot, a gynecologic oncologist at Baylor College of Medicine, will break down the research presented at the conference, discuss new developments, and address your questions. Key Takeaways: Our standard of care for sentinel lymph nodes […]

Report Back from SGO: What’s New in Ovarian Cancer Research?

Report Back from SGO: What’s New in Ovarian Cancer Research?

Are you curious about what’s new in ovarian cancer research? We invite you to join Dr. Premal Thaker, Distinguished Professor and interim Chief of Gynecologic Oncology at Siteman Cancer Center, to hear the latest updates from the Society of Gynecologic Oncology (SGO) Annual Meeting. Dr. Thaker will highlight what the research presented at the conference […]

SABCS Highlight Part II: Latest Ways to Think about Low-Risk DCIS

SABCS Highlight Part II

Join us for a discussion on the evolving understanding of Low-Risk DCIS and how these new insights can shape your care and decision-making. Our speakers will discuss the patient feedback from the COMET Study and its impact on others navigating similar choices. Plus, learn why donating biopsy tissue is vital for advancing discoveries that benefit […]

Donate